Corporate Governance

Investor Contact Sylke Maas, Ph.D.
VP Investor Relations & Business Strategy
Investors@biontech.de
+49 6131 9084-0
For U.S. Investors:
Westwicke
Victoria Meissner, M.D.
victoria.meissner@westwicke.com
+1 646 677-1837
Media Contact Jasmina Alatovic
Senior Manager Global External Communications
Media@biontech.de
+49 6131 9084-1513

Corporate Governance

Management Team
Supervisory Board

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.

Audit Committee Capital Markets Committee Compensation, Nominating and Corporate Governance Committee
Prof. Christopher Huber Audit Committee Compensation, Nominating and Corporate Governance Committee
Helmut Jeggle Capital Markets Committee
Michael Motschmann Audit Committee Capital Markets Committee Compensation, Nominating and Corporate Governance Committee
Dr. Ulrich Wandschneider Audit Committee Compensation, Nominating and Corporate Governance Committee
= Chairperson = Member = Financial Expert
= Chairperson = Member = Financial Expert for Audit Committee

Governance Documents

BioNTech SE Articles of Association Convenience Translation
BioNTech SE Satzung
General Purchasing Conditions / Allgemeine Einkaufsbedingungen (German only)
Code of Business Conduct & Ethics (DE)
Supplier Code of Conduct (EN)
Code of Business Conduct & Ethics (EN)
Supplier Code of Conduct (DE)
Corporate Governance Code Declaration of Conformity
Entsprechenserklärung zum Corporate Governance Kodex
Whistleblower Hotline BioNTech Hotline (anonymous)
Germany: 0800 000-8972
US: 844 901-0271
Other: +1 757 278-0107
Online Access to Whistle Blowing Reporting
Or by Email